By increasing public awareness of Cooled ThermoTherapy and Prostiva, Lifetime is providing a wonderful public service to help patients learn about BPH treatments that are far more effective than medications and avoid their side effects.
Minneapolis, MN (PRWEB) May 29, 2013
Urologix, Inc. (NASDAQ:ULGX) has partnered with The Balancing Act airing on Lifetime Television June 4th and 11th at 7:00 AM ET/PT. The show is set to discuss Benign Prostatic Hyperplasia (BPH) and educate BPH sufferers and their significant others on effective non-surgical, in-office treatment options as alternatives to BPH medications. Highlights from the upcoming show can be found at http://www.urologix.com.
BPH, also known as enlarged prostate, affects the majority of men as they age and can create irritating symptoms which significantly impact quality of life. This disease continues to be predominantly treated with medications; however, research has shown that drugs are not always effective and can produce unpleasant side effects. The Balancing Act segment will highlight safe, long-lasting and effective in-office BPH therapies which can be excellent alternatives to chronic medication. Cooled ThermoTherapy™ and Prostiva® RF Therapy, the market leading non-surgical options, have proven their results through numerous clinical studies and are recommended treatment options from the American Urology Association guidelines.
The show features Dr. Robert Pugach, Medical Director of the Pacific Coast Urology Medical Center, and Robert Munson, a BPH patient who underwent a Cooled ThermoTherapy procedure. Dr. Pugach is an expert on In-Office Therapy, having treated numerous patients over the past fifteen years using both Cooled ThermoTherapy and Prostiva RF Therapy.
“I was excited to participate in the Lifetime television feature on in-office minimally invasive treatment of Benign Prostate Hyperplasia,” stated Dr. Pugach after taping the segment. “By increasing public awareness of Cooled ThermoTherapy and Prostiva, Lifetime is providing a wonderful public service to help patients learn about BPH treatments that are far more effective than medications and avoid their side effects.“
Visit http://www.beatbph.com to learn more about BPH and other common prostatic conditions and to find a urologist near you.
Urologix, Inc., based in Minneapolis, develops, manufactures, markets and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). Urologix’s Cooled ThermoTherapy™ produces targeted microwave energy combined with a unique cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva® RF Therapy System delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH symptoms. Both of these therapies provide safe, effective and lasting relief of obstruction and symptoms due to BPH. Prostiva is a registered trademark of Medtronic, Inc., used under license. All other trademarks are the property of Urologix.
Federal USA law restricts these devices to sale by or on the order of a physician. For more complete information about the benefits, risks and contraindications associated with Cooled ThermoTherapy and Prostiva RF Therapy, please refer to the product labeling which accompanies the device and can be found at http://www.urologix.com.
If you would like more information on this topic, please contact Karen Jackson at 513-484-2987 or kjackson(at)urologix(dot)com. To learn more about Urologix and its products and services, visit http://www.urologix.com.
The Urologix logo is available at http://www.urologix.com/clinicians/resource-library.php.
Urologix Media Contact
Urologix Investor Relations Contact